Division of Pharmacology and Pathophysiology, Kinki University School of Pharmacy, Japan.
J Pharmacol Sci. 2013;122(4):244-50. doi: 10.1254/jphs.13r05cp. Epub 2013 Aug 1.
Low-voltage-activated T-type Ca(2+) channels (T-channels), especially Cav3.2 among the three isoforms (Cav3.1, Cav3.2, and Cav3.3), are now considered to play pivotal roles in processing of pain signals. Cav3.2 T-channels are functionally modulated by extracellular substances such as hydrogen sulfide and ascorbic acid, by intracellular signaling molecules including protein kinases, and by glycosylation. Cav3.2 T-channels are abundantly expressed in both peripheral and central endings of the primary afferent neurons, regulating neuronal excitability and release of excitatory neurotransmitters such as substance P and glutamate, respectively. Functional upregulation of Cav3.2 T-channels is involved in the pathophysiology of inflammatory, neuropathic, and visceral pain. Thus, Cav3.2 T-channels are considered to serve as novel targets for development of drugs for treatment of intractable pain resistant to currently available analgesics.
低电压激活 T 型钙(Ca2+)通道(T 型通道),尤其是三种亚型(Cav3.1、Cav3.2 和 Cav3.3)中的 Cav3.2,目前被认为在疼痛信号处理中发挥关键作用。Cav3.2 T 型通道可被包括蛋白激酶在内的细胞内信号分子以及糖基化等细胞外物质功能性调节。Cav3.2 T 型通道在初级传入神经元的外周和中枢末梢大量表达,分别调节神经元兴奋性和兴奋性神经递质如 P 物质和谷氨酸的释放。Cav3.2 T 型通道的功能上调参与了炎症性、神经性和内脏性疼痛的病理生理学过程。因此,Cav3.2 T 型通道被认为是开发治疗目前可用的镇痛剂无法缓解的顽固性疼痛药物的新型靶点。